675 related articles for article (PubMed ID: 15723039)
1. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
9. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.
Cheng KC; Wu WC
Kaohsiung J Med Sci; 2006 Jul; 22(7):321-30. PubMed ID: 16849100
[TBL] [Abstract][Full Text] [Related]
11. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
15. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Bakri SJ; Shah A; Falk NS; Beer PM
Eye (Lond); 2005 Jun; 19(6):686-8. PubMed ID: 15332099
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
Negi AK; Vernon SA; Lim CS; Owen-Armstrong K
Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
[TBL] [Abstract][Full Text] [Related]
19. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
20. Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.
Gelston CD; Olson JL; Mandava N
Acta Ophthalmol Scand; 2006 Jun; 84(3):314-8. PubMed ID: 16704690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
